NURS60042 5 Variable teaching patterns Postgraduate Taught Level 6 Joanne Timpson Unit coordinator Nursing & Midwifery 1 FHEQ level (Framework for Higher Education Qualifications) ' Masters/Integrated Masters P4 ' European Credit Transfer & Accumulation System Rating : 2.5 <p>Car T Cell Therapy is a new and potentially revolutionary development in the treatment of Haematological cancers.</p><p>The Christie Hospital N.H.S. Trust, a leading Cancer Centre of excellence and with whom we have a collaborative partnership has been licensed to deliver this type of treatment.</p><p>Other Cancer centres in the U.K. are applying for licenses to use this treatment (e.g. Leeds, Newcastle, Sheffield, and London) and so there is a need for C.P.D. education to support this type of care delivery nationally as well as locally.</p><p>The therapy is also currently being trialled in the solid tumour group and therefore moving forward there is a potentially large future market which will require education to understand the principles of this type of therapy and how to manage the toxicities which can arise from its use.</p><p>The design of the 5 credit unit / 2 study day deliveries facilitates release of staff and can be used in conjunction with other 5 credit units in development to from a 15 credit portfolio to feed into existing P.G. Masters programmes.</p> <p>The content of the two study days will from part of the current / existing Principles of Haematology Oncology course unit ( an approved 15 credit level 7 unit )</p><p>Key themes</p><ul> <li>Principles and mechanisms of CART Cell therapy.</li> <li>Advanced therapies in clinical trials in haematology for haematological and solid tumour groups.</li> <li>Ethical issues and informed consent.</li> <li>Psychological support.</li> <li>The management of toxicities of treatment.</li> <li>The patient experience.</li> <li>Enhanced supportive care delivery.</li> <li>Multi- agency and multi-disciplinary team working.</li> <li>Organisation and provision of services.</li> <li>Current key policies and their impact upon care delivery.</li> <li>Treatment choices / pathways and service development.</li></ul> <p>This unit aims to:</p><ul> <li>Develop student&rsquo;s understanding of the principles, mechanism of action and toxicities associated with treatment using CAR T Cell therapy.</li> <li>Critically examine the complex needs of Haematology oncology patients within this context of changing healthcare provision and the use of evidence based practice.</li> <li>Critically evaluate current national and local policy, clinical guidelines, protocols for care delivery, evidenced based practice and analyse their influence in the identification, treatment and management of haematological malignancies.</li></ul><p>Enhance the knowledge and skills required to develop care packages / pathways of treatment for patients requiring CART Cell therapy.</p> <ul> <li>Critically examine the physical, social and psychological needs of patients with haematological malignancy and justify how these are assessed and managed in the students own service and by the multi professional/multi agency teams identifying areas for development and change.</li> <li>Critically analyse and evaluate the ethical, cultural, religious, and spiritual and quality of life issues associated with haematological malignancy and critically examine how such issues are addressed in day-to-day practice.</li> <li>Critically evaluate patient-centred care and patient choice in decision-making, demonstrating use of educational tools and understanding of the patient pathway.</li> <li>Evaluate current treatments options and justify best practice identifying areas for service development and delivery.</li></ul> <ul> <li>Critically evaluate current practice and service delivery and, drawing on a range of evidence; propose innovative approaches to enhancing care for patients undergoing CAR T Cell Therapy.</li></ul> <ul> <li>Communicate developments in practice to the multidisciplinary team.</li></ul> <ul> <li>Evaluate their own role in leading and developing practice and service delivery in relation to the care of patients undergoing CAR T Cell Therapy.</li></ul> 2 Written assignment (inc essay) 100% PGT Stand Alone Units PGT Stand Alone (5 Credits) PGDT Taught Component Optional N Lectures 12 Tutorials 2 36